2 ms·
There's not much - actually no - tech-for-tech's-sake. I'd guess that's more of a good thing than a bad one. IMO the bio/med slant and almost (not quite...) c
by TheOtherHobbes 12y ago
There's not much - actually no - tech-for-tech's-sake.
I'd guess that's more of a good thing than a bad one.
IMO the bio/med slant and almost (not quite...) complete absence of anything social or IoT is interesting, and possibly an indicator of future YC strategy.
I'm slightly surprised some of these projects think they need YC. E.g. if MashGin is anywhere close to working it's likely going to have investors dropping off big piles of cash at their lab day, night, weekends, and major holidays.